Home

PB Ratio of Concord Biotech Ltd

Image

Concord Biotech Ltd

NSE: CONCORDBIO

PB Ratio

14.4

Last updated on: Dec 26, 2024

Key Highlights

  • The latest PB Ratio of Concord Biotech Ltd is 14.4.
  • The PB ratio of the Concord Biotech Ltd is above 3 which indicates that the stock is overvalued but this is common in high-growing sectors.
  • The P/B Ratio of Concord Biotech Ltd changed from 10.4 on March 2024 to 10.4 on March 2024 . This represents a CAGR of 0.00% over 1 years.

Historical P/B Ratio of Concord Biotech Ltd

No data available

Company Fundamentals for Concord Biotech Ltd

Market Cap

22,873 Cr

EPS

31.4

P/E Ratio (TTM)

69.7

P/B Ratio (TTM)

14.4

Day’s High

2248.95

Day’s Low

2169.3

DTE

0.0

ROE

20.6

52 Week High

2658.0

52 Week Low

1326.9

ROCE

27.8

Market Price of Concord Biotech Ltd

1M

1Y

3Y

5Y

Monitoring Concord Biotech Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
26 Dec 20242186.4
24 Dec 20242148.65
23 Dec 20242133.6
20 Dec 20242127.5
19 Dec 20242129.4

SWOT Analysis Of Concord Biotech Ltd

Strength

2

che

Weakness

2

che

Opportunity

0

che

Threats

1

che

BlinkX Score for Concord Biotech Ltd

Asset Value vs Market Value of Concord Biotech Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/B Ratio

Historical Market Cap of Concord Biotech Ltd

Market Cap

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Concord Biotech Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

FAQs for PB Ratio of Concord Biotech Ltd

What is the PB ratio of Concord Biotech Ltd?

The current PB ratio of Concord Biotech Ltd is 14.38. The Price-to-Book value (P/B) ratio compares a company's current share price to its book value per share. It helps assess whether a stock is overvalued or undervalued relative to its net asset value.

What is the ideal PB ratio to buy Concord Biotech Ltd stocks?

An ideal PB ratio varies by industry; however, a PB ratio below 1.0 may indicate a good buying opportunity for Concord Biotech Ltd. Some investors and financial analysts may also consider any value under 3.0 as a good PB ratio.

How is the PB Ratio of Concord Biotech Ltd calculated?

The PB ratio of Concord Biotech Ltd is calculated by dividing the current share price by the book value per share. The book value per share is determined by dividing the company’s total net assets (assets minus liabilities) by the number of outstanding shares. This ratio helps evaluate how the market values the company's assets.

What does a high PB Ratio mean for Concord Biotech Ltd?

A high PB ratio suggests that Concord Biotech Ltd’s stock may be overvalued relative to its book value or that investors expect high growth.

What does a low PB Ratio indicate for Concord Biotech Ltd?

A low PB ratio of Concord Biotech Ltd may indicate that the stock is undervalued or it is facing financial difficulties.

Can Concord Biotech Ltd PB Ratio change over time?

Yes, the PB ratio of Concord Biotech Ltd can change over time due to fluctuations in the company’s stock price and changes in its book value.

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions